Výsledky vyhledávání - Suzanne Lentzsch

Upřesnit hledání
  1. 1
    Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis

    Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis Autor Rajshekhar Chakraborty, Divaya Bhutani, Mathew S. Maurer, Meera Mohan, Suzanne Lentzsch, Anita D’Souza

    Vydáno 2023
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells

    Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells Autor Suzanne Lentzsch, Margarete Gries, Martin Janz, Ralf C. Bargou, Bernd Dörken, Markus Y. Mapara

    Vydáno 2003
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    The histone deacetylase inhibitor, PXD101, potentiates bortezomib‐induced anti‐multiple myeloma effect by induction of oxidative stress and DNA damage

    The histone deacetylase inhibitor, PXD101, potentiates bortezomib‐induced anti‐multiple myeloma effect by induction of oxidative stress and DNA damage Autor Rentian Feng, Ana B. Oton, Markus Y. Mapara, Gülsüm Anderson, Chandra P. Belani, Suzanne Lentzsch

    Vydáno 2007
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1

    Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves... Autor Corinna Leng, Margarethe Gries, Judy Ziegler, Anna Lokshin, Paolo Mascagni, Suzanne Lentzsch, Markus Y. Mapara

    Vydáno 2006
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation

    Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation Autor Guoshuang Xu, Kai Liu, Judy M. Anderson, Kenneth D. Patrene, Suzanne Lentzsch, G. David Roodman, Hongjiao Ouyang

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice

    Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice Autor Huihui Ma, Caisheng Lu, Judith Ziegler, Ailing Liu, Antonia R. Sepulveda, Hideho Okada, Suzanne Lentzsch, Markus Y. Mapara

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    IMiD immunomodulatory compounds block C/EBPβ translation through eIF4E down-regulation resulting in inhibition of MM

    IMiD immunomodulatory compounds block C/EBPβ translation through eIF4E down-regulation resulting in inhibition of MM Autor Shirong Li, Rekha Pal, Sara A. Monaghan, Peter Schäfer, Hongjiao Ouyang, Markus Y. Mapara, Deborah L. Galson, Suzanne Lentzsch

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway

    In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway Autor Manik Chatterjee, Dirk Hönemann, Suzanne Lentzsch, Kurt Bommert, Christine Sers, Pia Herrmann, Stephan Mathas, Bernd Dörken, Ralf C. Bargou

    Vydáno 2002
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study

    Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study Autor Suzanne Lentzsch, Galina Lagos, Raymond L. Comenzo, Jeffrey A. Zonder, Keren Osman, Samuel Pan, Divaya Bhutani, Silva Pregja, Vaishali Sanchorawala, Heather Landau

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease

    The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease Autor Jing Fu, Shirong Li, Huihui Ma, Jun Yang, Gabriel M. Pagnotti, Lewis M. Brown, Stephen J. Weiss, Markus Y. Mapara, Suzanne Lentzsch

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia

    Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia Autor Kenneth A. Foon, Dhaval Mehta, Suzanne Lentzsch, Patricia Kropf, Stanley M. Marks, Diana Lenzner, L. Pietragallo, M. Sulecki, Ahmad A. Tarhini, Michael Boyiadzis

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis

    Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis Autor Camille V. Edwards, Nisha Rao, Divaya Bhutani, Markus Y. Mapara, Jai Radhakrishnan, Sofia Shames, Mathew S. Maurer, Siyang Leng, Alan Solomon, Suzanne Lentzsch, Andrew Eisenberger

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia

    Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia Autor Rekha Pal, Sara A. Monaghan, Andrea Cortese Hassett, Markus Y. Mapara, Peter Schäfer, G. David Roodman, Margaret V. Ragni, Lynn C. Moscinski, Alan F. List, Suzanne Lentzsch

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells

    C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells Autor Rekha Pal, Martin Janz, Deborah L. Galson, Margarete Gries, Shirong Li, Korinna Jöhrens, Ioannis Anagnostopoulos, Bernd Dörken, Markus Y. Mapara, Lisa Borghesi, Lela Kardava, G. David Roodman, Christine Milcarek, Suzanne Lentzsch

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Diffuse Lung Involvement as a Rare Presentation of Systemic AL Amyloidosis: A Retrospective Cohort Study

    Diffuse Lung Involvement as a Rare Presentation of Systemic AL Amyloidosis: A Retrospective Cohort Study Autor Amy Song, George Mellgard, Claudia Bellofiore, Marco Basset, Mario Nuvolone, Andrea Foli, Giampaolo Merlini, Matthew J. Maurer, Markus Y. Mapara, Divaya Bhutani, Suzanne Lentzsch, Hiram Shaish, Giovanni Palladini, Rajshekhar Chakraborty, Paolo Milani

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease

    Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease Autor Jing Fu, Shirong Li, Rentian Feng, Huihui Ma, Farideh Sabeh, G. David Roodman, Ji Wang, Samuel T. Robinson, X. Edward Guo, Thomas Lund, Daniel P. Normolle, Markus Y. Mapara, Stephen J. Weiss, Suzanne Lentzsch

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study

    Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 o... Autor Suzanne Lentzsch, Amy K. O’Sullivan, Ryan Kennedy, Mohammad Abbas, Lijun Dai, Silvana Pregja, Steve Burt, Michael Boyiadzis, G. David Roodman, Markus Y. Mapara, Mounzer Agha, John Waas, Yongli Shuai, Daniel P. Normolle, Jeffrey A. Zonder

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma

    Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma Autor Jatin J. Shah, Edward A. Stadtmauer, Rafat Abonour, Adam D. Cohen, William Bensinger, Cristina Gasparetto, Jonathan L. Kaufman, Suzanne Lentzsch, Dan T. Vogl, Christina L. Gomes, N G Pascucci, David Smith, Robert Z. Orlowski, Brian G.M. Durie

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group

    Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone... Autor Lia A. Moulopoulos, Vassilis Koutoulidis, Jens Hillengaß, Elena Zamagni, Jesús Dámaso Aquerreta, Charles Roche, Suzanne Lentzsch, Philippe Moreau, Michèle Cavo, Jesús F. San Miguel, Meletios Α. Dimopoulos, S. Vincent Rajkumar, Brian G.M. Durie, Evangelos Terpos, Stefan Delorme

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

    Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy Autor Anjan Thakurta, Anita K. Gandhi, Michelle F. Waldman, Chad C. Bjorklund, Yuhong Ning, Derek Mendy, Peter Schäfer, Antonia López-Girona, Suzanne Lentzsch, Steve Schey, Yolanda Calle, Rajani Chelliah, Robert Z. Orlowski, Anup Madan, Hervé Avet‐Loiseau, Rajesh Chopra

    Vydáno 2013
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: